您所在的位置: 首页 --> 导师团队 --> 王崑

导师基本信息

  • 姓名:王崑
  • 性别:
  • 民族:汉族
  • 科室:肝胆胰外科-I
  • 职称:主任医师,教授
  • 专业:肿瘤学、肿瘤外科学
  • E-MAIL: wang-kun@vip.sina.com

学术论文 | 科研项目

Hai-bin Zhu1 , Da Xu2 , Xue-Feng Sun1 , Xiao-Ting Li1, Xiao-Yan Zhang1, Kun Wang2*, Bao-Cai Xing2* and Ying-Shi Sun1* ,prediction of hepatic lymp0h node metastases based on magnetic resonance imaging before and after preoperative chemotherapy in patients with colorectal liver metastases underwent surgical resection,cancer imagin,23(1):18

Liu, W., Jin, K. M., Zhang, M. H., Bao, Q., Liu, M., Xu, D., Wang, K., & Xing, B. C. (2023). Recurrence Prediction by Circulating Tumor DNA in the Patient with Colorectal Liver Metastases After Hepatectomy: A Prospective Biomarker Study.,Ann Surg Oncol,online a head print

3. Wei, X., Ye, J., Pei, Y., Wang, C., Yang, H., Tian, J., Si, G., Ma, Y., Wang, K., & Liu, G. (2022). Extracellular vesicles from colorectal cancer cells promote metastasis via the NOD1 signalling pathway,J EXTRACELL VESICLES,11(9):e12264

Wang, K., Liu, M., Wang, H. W., Jin, K. M., Yan, X. L., Bao, Q., Xu, D., Wang, L. J., Liu, W., Wang, Y. Y., Li, J., Liu, L. J., Zhang, X. Y., Yang, C. H., Jin, G., & Xing, B. C. . Mutated DNA Damage Repair Pathways Are Prognostic and Chemosensitivity Markers for Resected Colorectal Cancer Liver Metastases,Front Oncol,11:643375

Jin KM, Liu W, Wang K, Bao Q, Wang HW and Xing BC. The individualized selection of Pancreaticoenteric anastomosis in Pancreaticoduodenectomy [J]. BMC Surg, 2020, 20(1): 140.,BMC Surg,2020, 20(1): 140.

8. Liu, J. M., Wang, Y. Y., Liu, W., Xu, D., Wang, K., & Xing, B. C. (2022). Long disease-free interval diminishes the prognostic value of primary tumor stage for patients with colorectal cancer liver metastases.,HPB (Oxford),24(5), 737-748.

Liu, M., Wang, K., Wang, Y., Bao, Q., Wang, H., Jin, K., Liu, W., & Xing, B. (2021). Short- and long-term outcomes of hepatectomy combined with intraoperative radiofrequency ablation for patients with multiple primarily unresectable colorectal liver metastases: a propensity matching analysis.,HPB (Oxford),23(10):1586—1594

2. Wang, Y. Y., Dong, K., Wang, K., Sun, Y., & Xing, B. C. (2023). Effect of vessels that encapsulate tumor clusters (VETC) on the prognosis of different stages of hepatocellular carcinoma after hepatectomy.,Dig Liver Dis,online a head print

Gu, X. L., Cui, Y., Wang, K., Xing, Q., Li, X. T., Zhu, H. T., Li, Z. W., & Sun, Y. S. (2022). Qualitative and quantitative parameters on hepatobiliary phase of gadoxetic acid-enhanced MR imaging for predicting pathological response to preoperative systemic therapy in colorectal liver metastases.,Eur J Radiol,157, 110572

Liu, J. M., Wang, Y. Y., Liu, W., Xu, D., Wang, K., & Xing, B. C. (2021). Preoperative CA19-9: a competitive predictor of recurrence in patients with colorectal cancer liver metastases after hepatectomy,Int J Colorectal Dis,36(4), 767-778

21. Hu, H., Wang, K., Huang, M., Kang, L., Wang, W., Wang, H., Qiu, M., Lin, R., Zhang, H., Lan, P., Wu, X., Liu, G., Wan, Y., Liu, M., Zhou, Z., Huang, Y., Li, F., Zhang, J., Cai, Y., Ma, T., Zhou, J., Wang, H., Ling, J., Cai, Y., Wu, Z., Luo, S., Ling, L., & Deng, Y. (2021). Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II Trial,Oncologist,26(1), e90-e98

Bao, X., Wang, K., Liu, M., Li, B., Wang, H., Jin, K., Yan, X., Zhang, H., Bao, Q., Xu, D., Wang, L., Liu, W., Wang, Y., Li, J., Liu, L., Fang, W., & Xing, B. (2021). Characterization of Genomic Alterations in Colorectal Liver Metastasis and Their Prognostic Value,Front Cell Dev Biol,9, 760618.

Xu, D., Wang, Y. Y., Yan, X. L., Li, J., Wang, K., & Xing, B. C. (2021). Development of a model to predict pathologic response to chemotherapy in patients with colorectal liver metastases.,J Gastrointest Oncol,12(4), 1498-1508

Liu, W., Liu, J. M., Wang, K., Wang, H. W., & Xing, B. C. (2021). Recurrent colorectal liver metastasis patients could benefit from repeat hepatic resection,BMC Surg,21(1), 327

11. Zhang, C., Hu, C., Su, K., Wang, K., Du, X., Xing, B., & Liu, X. (2021). The Integrative Analysis of Thrombospondin Family Genes in Pan-Cancer Reveals that THBS2 Facilitates Gastrointestinal Cancer Metastasis,J Oncol,4405491

Yan, X. L., Wang, K., Bao, Q., Wang, H. W., Jin, K. M., Wang, J. Y., & Xing, B. C. (2021). En bloc right hemicolectomy with pancreatoduodenectomy for right-sided colon cancer invading duodenum,BMC Surg,21(1), 302

Wang LJ, Yan XL, Li J, Wang K and Xing BC. Indocyanine Green Clearance Test for the Preoperative Assessment of Chemotherapy-Related Hepatic Injury in Patients with Colorectal Liver Metastasis [J]. Cancer Manag Res, 2020, 12: 3237-3245.,Cancer Manag Res,,2020, 12: 3237-3245.

Wang YY, Xiang BD, Ma L, Zhong JH, Ye JZ, Wang K, Xing BC and Li LQ. Development and Validation of a Nomogram to Preoperatively Estimate Post-hepatectomy Liver Dysfunction Risk and Long-term Survival in Patients With Hepatocellular Carcinoma [J]. Ann Surg, 2020.,Ann Surg,

Liu W, Wang K#, Han Y, Liang JY, Li YH, Xing BCNomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection,Eur J Surg Oncol,2019 Nov;45(11):2070-2077

Wang YY, Liu ZZ, Xu D, Liu M, Wang K and Xing BC. Fibrinogen-Albumin Ratio Index (FARI): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Hepatectomy for Colorectal Liver Metastases [J]. Ann Surg Oncol, 2019, 26(11): 3682-3692,Ann Surg Oncol,2019, 26(11): 3682-3692

Pfitzinger, P. L., Fangmann, L., Wang, K., Demir, E., Gürlevik, E., Fleischmann-Mundt, B., Brooks, J., D'Haese, J. G., Teller, S., Hecker, A., Jesinghaus, M., J?ger, C., Ren, L., Istvanffy, R., Kühnel, F., Friess, H., Ceyhan, G. O., & Demir, I. E. (2020). Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation.,J Exp Clin Cancer Res,39(1), 289

Jin, K. M., Liu, W., Wang, K., Bao, Q., Wang, H. W., & Xing, B. C. (2020). The individualized selection of Pancreaticoenteric anastomosis in Pancreaticoduodenectomy,BMC Surg,20(1), 140

AATF调控肿瘤干细胞特性和EMT在结直肠癌转移和复发中的作用及机制 研究, 课题负责人, 2020.1.1~2023.12.31, 国家自然科学基金委员会,面上项目,项目批准号:31971192

社会任职

  • 北京癌症防治学会 原发性肝癌外科治疗专委会 主任委员
  • 中国医师协会 结直肠肿瘤专业委员会 肝转移委员会秘书长
  • 中国医师协会 肿瘤外科专业委员会 青委副主任委员 中国医促会肝癌专业委员会 委员 中国医师协会 MDT专业委员会 委员 中国抗癌协会胆道外科 委员 中国医促会结直肠癌肝转移委员会 委员 北京健康促进会 中青年专家委员会肝癌专业委员会 副主任委员

学习、工作经历

  • 2021.8.1~,教授
  • 2019.12.19~2023.12.19,博士生导师
  • 2014.7.12~,北京大学临床肿瘤学院肝胆外科,主任医师
  • 2011.7.12~2016.12.12,北京大学临床肿瘤学院临床药理机构,副主任
  • 2011.6.12~2016.12.12,北京大学临床肿瘤学院肝胆外科,副主任